Anti-GLT12/ GALNT12/ CRCS1 functional antibody

Anti-GLT12/ GALNT12/ CRCS1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to GALNT12/GALNT12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0234-Ab-1/ GM-Tg-hg-SE0234-Ab-2Anti-Human GALNT12 monoclonal antibodyHuman
GM-Tg-rg-SE0234-Ab-1/ GM-Tg-rg-SE0234-Ab-2Anti-Rat GALNT12 monoclonal antibodyRat
GM-Tg-mg-SE0234-Ab-1/ GM-Tg-mg-SE0234-Ab-2Anti-Mouse GALNT12 monoclonal antibodyMouse
GM-Tg-cynog-SE0234-Ab-1/ GM-Tg-cynog-SE0234-Ab-2Anti-Cynomolgus/ Rhesus macaque GALNT12 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0234-Ab-1/ GM-Tg-felg-SE0234-Ab-2Anti-Feline GALNT12 monoclonal antibodyFeline
GM-Tg-cang-SE0234-Ab-1/ GM-Tg-cang-SE0234-Ab-2Anti-Canine GALNT12 monoclonal antibodyCanine
GM-Tg-bovg-SE0234-Ab-1/ GM-Tg-bovg-SE0234-Ab-2Anti-Bovine GALNT12 monoclonal antibodyBovine
GM-Tg-equg-SE0234-Ab-1/ GM-Tg-equg-SE0234-Ab-2Anti-Equine GALNT12 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0234-Ab-1/ GM-Tg-hg-SE0234-Ab-2; GM-Tg-rg-SE0234-Ab-1/ GM-Tg-rg-SE0234-Ab-2;
GM-Tg-mg-SE0234-Ab-1/ GM-Tg-mg-SE0234-Ab-2; GM-Tg-cynog-SE0234-Ab-1/ GM-Tg-cynog-SE0234-Ab-2;
GM-Tg-felg-SE0234-Ab-1/ GM-Tg-felg-SE0234-Ab-2; GM-Tg-cang-SE0234-Ab-1/ GM-Tg-cang-SE0234-Ab-2;
GM-Tg-bovg-SE0234-Ab-1/ GM-Tg-bovg-SE0234-Ab-2; GM-Tg-equg-SE0234-Ab-1/ GM-Tg-equg-SE0234-Ab-2
Products NameAnti-GALNT12 monoclonal antibody
Formatmab
Target NameGALNT12
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GALNT12 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0234-Ag-1Recombinant multi-species GLT12/ GALNT12/ CRCS1 protein


    Target information

    Target IDGM-SE0234
    Target NameGALNT12
    Gene ID79695,230145,313233,715128,474777,101093556,508488,100063861
    Gene Symbol and Synonyms9130206E10,A630062B03Rik,CRCS1,GalNAc-T12,GALNT12,mpp-GalNAc-T12,pp-GaNTase,RGD1562001
    Uniprot AccessionQ8IXK2
    Uniprot Entry NameGLT12_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000119514
    Target ClassificationN/A

    The target: GALNT12, gene name: GALNT12, also named as CRCS1, GalNAc-T12. This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer.[provided by RefSeq, Mar 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.